INOVIQ Ltd (IIQ.AX)
AUD 0.36
(0.0%)
AUD 0.36
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -6.63 Million AUD | 26.48% |
| 2023 | -9.02 Million AUD | -45.88% |
| 2022 | -5.67 Million AUD | -628.15% |
| 2021 | -6.04 Million AUD | 140.45% |
| 2020 | - AUD | -25.75% |
| 2019 | - AUD | -14.34% |
| 2018 | -1.86 Million AUD | 19.07% |
| 2017 | -2.48 Million AUD | 13.17% |
| 2016 | -2.83 Million AUD | -2.44% |
| 2015 | -4.49 Million AUD | -2.87% |
| 2014 | 1.62 Million AUD | -2154.94% |
| 2013 | -10.96 Million AUD | 88.01% |
| 2012 | -8.23 Million AUD | -33.47% |
| 2011 | -1.22 Million AUD | -146.37% |
| 2010 | -788.83 Thousand AUD | 169.84% |
| 2009 | -1.13 Million AUD | -87.21% |
| 2008 | 3.6 Million AUD | 1387.65% |
| 2007 | -365.76 Thousand AUD | -115.44% |
| 2006 | -3.45 Million AUD | 204.13% |
| 2005 | -2.27 Million AUD | -89.1% |
| 2004 | -1.17 Million AUD | 13.82% |
| 2003 | -1.39 Million AUD | -2290.66% |
| 2002 | 63.74 Thousand AUD | 0.0% |
| 1999 | -1.57 Million AUD | -139.92% |
| 1998 | -657.34 Thousand AUD | -526.86% |
| 1997 | 153.99 Thousand AUD | 1031.39% |
| 1996 | 13.61 Thousand AUD | -91.95% |
| 1995 | 169 Thousand AUD | 137.98% |
| 1994 | -445 Thousand AUD | -1880.0% |
| 1993 | 25 Thousand AUD | 104.28% |
| 1992 | -584 Thousand AUD | -36.45% |
| 1991 | -428 Thousand AUD | 13.36% |
| 1990 | -494 Thousand AUD | 89.86% |
| 1989 | -4.87 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1.35 Million AUD | 66.88% |
| 2024 Q4 | -1.47 Million AUD | -162.9% |
| 2024 FY | - AUD | 29.59% |
| 2024 Q2 | -1.35 Million AUD | -167.14% |
| 2024 Q3 | -1.48 Million AUD | 59.04% |
| 2023 FY | - AUD | -45.88% |
| 2023 Q1 | -2.44 Million AUD | -49.0% |
| 2023 Q2 | -2.44 Million AUD | 0.0% |
| 2023 Q3 | -1.3 Million AUD | 46.72% |
| 2023 Q4 | -1.47 Million AUD | -13.58% |
| 2022 Q2 | -1.49 Million AUD | 0.0% |
| 2022 Q3 | -1.93 Million AUD | -29.91% |
| 2022 Q1 | -1.49 Million AUD | 55.8% |
| 2022 FY | - AUD | -628.15% |
| 2022 Q4 | -1.64 Million AUD | 15.35% |
| 2021 Q2 | -2.99 Million AUD | -76.29% |
| 2021 Q4 | -3.37 Million AUD | -154.44% |
| 2021 FY | - AUD | 140.45% |
| 2021 Q1 | -1.69 Million AUD | -33.0% |
| 2021 Q3 | -1.32 Million AUD | 55.66% |
| 2020 Q4 | -1.27 Million AUD | -167.38% |
| 2020 Q2 | -1.61 Million AUD | -5392.31% |
| 2020 Q1 | 30.58 Thousand AUD | -5.56% |
| 2020 FY | - AUD | -25.75% |
| 2020 Q3 | -477.38 Thousand AUD | 70.51% |
| 2019 Q1 | -302.00 AUD | 99.94% |
| 2019 FY | - AUD | -14.34% |
| 2019 Q3 | 32.38 Thousand AUD | 10788.45% |
| 2019 Q2 | -303.00 AUD | -0.33% |
| 2019 Q4 | 32.38 Thousand AUD | 0.0% |
| 2018 Q4 | -509.84 Thousand AUD | 0.0% |
| 2018 FY | - AUD | 19.07% |
| 2018 Q3 | -509.84 Thousand AUD | -20.82% |
| 2018 Q2 | -421.96 Thousand AUD | 0.0% |
| 2018 Q1 | -421.96 Thousand AUD | 36.22% |
| 2017 Q1 | -580.07 Thousand AUD | 0.0% |
| 2017 Q2 | -580.07 Thousand AUD | 0.0% |
| 2017 FY | - AUD | 13.17% |
| 2017 Q4 | -661.55 Thousand AUD | 0.0% |
| 2017 Q3 | -661.55 Thousand AUD | -14.05% |
| 2016 FY | - AUD | -2.44% |
| 2015 FY | - AUD | -2.87% |
| 2014 FY | - AUD | -2154.94% |
| 2013 FY | - AUD | 88.01% |
| 2012 FY | - AUD | -33.47% |
| 2011 FY | - AUD | -146.37% |
| 2010 FY | - AUD | 169.84% |
| 2009 FY | - AUD | -87.21% |
| 2008 FY | - AUD | 1387.65% |
| 2007 FY | - AUD | -115.44% |
| 2006 FY | - AUD | 204.13% |
| 2005 FY | - AUD | -89.1% |
| 2004 FY | - AUD | 13.82% |
| 2003 FY | - AUD | -2290.66% |
| 2002 FY | - AUD | 0.0% |
| 1999 FY | - AUD | -139.92% |
| 1998 FY | - AUD | -526.86% |
| 1997 FY | - AUD | 1031.39% |
| 1996 FY | - AUD | -91.95% |
| 1995 FY | - AUD | 137.98% |
| 1994 FY | - AUD | -1880.0% |
| 1993 FY | - AUD | 104.28% |
| 1992 FY | - AUD | -36.45% |
| 1991 FY | - AUD | 13.36% |
| 1990 FY | - AUD | 89.86% |
| 1989 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Australian Clinical Labs Limited | 181.83 Million AUD | 103.648% |
| BCAL Diagnostics Limited | -5.66 Million AUD | -17.057% |
| Genetic Signatures Limited | -20.33 Million AUD | 67.384% |
| Genetic Technologies Limited | -11.43 Million AUD | 41.969% |
| Healius Limited | -298.09 Million AUD | 97.775% |
| Imagion Biosystems Limited | -13.69 Million AUD | 51.57% |
| Integral Diagnostics Limited | 12.33 Million AUD | 153.781% |
| Microba Life Sciences Limited | -22.8 Million AUD | 70.918% |
| Monash IVF Group Limited | 13.02 Million AUD | 150.928% |
| Rhythm Biosciences Limited | -6.79 Million AUD | 2.391% |
| Sonic Healthcare Limited | 1.65 Billion AUD | 100.4% |